首页> 外文期刊>International Journal of Cancer =: Journal International du Cancer >Determination of the origin of oral squamous cell carcinoma by microarray analysis: Squamous epithelium or minor salivary gland?
【24h】

Determination of the origin of oral squamous cell carcinoma by microarray analysis: Squamous epithelium or minor salivary gland?

机译:微阵列分析测定口腔鳞状细胞癌的起源:鳞状上皮还是轻涎腺鳞状?

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

More than 90% of oral cancers are histopathologically squamous cell carcinomas (SCCs). According to clinical behavior and histopathological features, we hypothesize that oral SCC can originate from either oral squamous epithelium or minor salivary glands. Here, we examined whether some oral SCCs originate from minor salivary glands, and investigated whether these tumors show particularly aggressive biological behavior. The mRNA expression profiles of samples obtained from six patients with oral floor SCC (five men, one woman; mean age, 62.7 years) were analyzed using a microarray containing 32,878 probes. The six samples were divided into two groups by clustering of expression levels of 845 probes differentially expressed in normal oral squamous epithelium and normal salivary glands. The expression profile in four cases was similar to that of normal oral squamous epithelium, and in two cases was similar to that of normal salivary glands. Furthermore, we identified nine genes that reveal the origin of the oral SCC. Subsequently, we examined the expression levels of these nine marker genes by reverse transcriptase‐polymerase chain reaction to determine the origin of 66 oral SCCs. Twelve of the 66 oral SCCs were considered to originate from minor salivary glands, and these tumors showed high metastatic potential ( p = 0.044, Chi‐square test). Furthermore, SCC derived from minor salivary glands showed a poor event‐free survival rate ( p = 0.017, Kaplan–Meier analysis). In conclusion, determination of the origin of oral SCC is helpful in planning treatment for patients with oral SCC.
机译:超过90%的口腔癌是组织病理学上鳞状细胞癌(SCCS)。根据临床行为和组织病理学特征,我们假设口服SCC可以源自口腔鳞状上皮或轻微唾液腺。在这里,我们检查了一些口服SCC是否源于轻微的唾液腺,并研究了这些肿瘤是否表现出特别侵略性的生物行为。使用含有32,878个探针的微阵列分析从六个口服地板SCC(五种男性,一个女人;平均年龄,62.7岁)获得的样品的mRNA表达谱。通过在正常口腔鳞状上皮和正常唾液腺中差异表达的845探针的表达水平分为两组,将六个样品分成两组。在四个病例中表达谱类似于正常口腔上皮上皮,两种情况类似于正常唾液腺的两种情况。此外,我们鉴定了揭示口服SCC的起源的九个基因。随后,我们通过逆转录酶 - 聚合酶链反应检查了这些九个标记基因的表达水平,以确定66个口服SCC的起源。认为66个口服SCC的十二次源自轻率唾液腺,这些肿瘤显示出高转移性潜力(P = 0.044,Chi-Square测试)。此外,来自轻微唾液腺的SCC显示出无数的无事项存活率(P = 0.017,Kaplan-Meier分析)。总之,口服SCC的起源的测定有助于对口服SCC患者进行规划治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号